Skip to main content
. 2016 Sep 1;4(3):e105. doi: 10.2196/mhealth.5921

Table 2.

Characteristics of studies using smartphone interventions with COPD patients.

First author, (year) COPDa stage FEV1b, mean (SD), % predicted Participant age (years), mean (SD), Male
sex, %
Sample size
(analyzed)
No. of patients having an exacerbation
IGc CGd IG CG IG CG IG CG IG CG
Tabak,
(2014)
[24]
All stages

48.7
(16.7)
56.4
(10.6)
65.2 (9.0) 67.9
(5.7)
57% 68% 15
(10)
15
(2)
33 N/Re
Pedone, (2013) [21] II or III 52.5 (14.9) 55.4
(15.8)
74.1 (6.4) 75.4
(6.7)
72% 63% 50
(39)
49
(49)
9 15

Jehn,
(2013)
[23]
II-IV 50.2
(15)
52.6
(17.5)
64.1
(10.9)
69.1
(9.2)
81% 73% 32 (32) 30 (30) 7 22
Halpin, (2011)
[20]
All stages 48 (4) 54 (3) 68.5 (1.5) 70.2 (1.6) 74% 73% 40 (39) 39 (38) 23 26
Nguyen,
(2008)
[19]
All stages 49.0 (16.8) 50.3 (17.6) 68.0 (8.3) 70.9 (8.6) 61% 55% 26 (20) 24 (19) 10 N/R
Liu,
(2008)
[22]
II or III 45.2(3.2) 46 (2.8) 71.4 (1.7) 72.8 (1.3) 100% 100% 30 (24) 30 (24) 2 10

aCOPD: Chronic Obstructive Pulmonary Disease.

bFEV1: Forced Expiratory Volume in one second.

cIG: Intervention Group.

dCG: Control Group.

eN/R: not reported.